1. Doi M, Morita K, Takeda J, Sakamoto A, Yamakage M, Suzuki T. Efficacy and safety of remimazolam versus propofol for general anesthesia: a multicenter, single-blind, randomized, parallel-group, phase IIb/III trial. J Anesth. 2020;34:543-53.
2. Gary ST, Gavine K. CNS 7056X, an ultra-short acting benzodiazepine: in vitro metabolism. Anesthesiology. 2006;105:A1611.
3. Onoda A, Suzuki Y. A new anesthetic, remimazolam, is useful in the management of anesthesia in patients with liver cirrhosis. Case Rep Anesthesiol. 2022;2022:9268454.
4. Dahaba AA, Worm HC, Zhu SM, et al. Sensitivity and specificity of bispectral index for classification of overt hepatic encephalopathy: a multicentre, observer blinded, validation study. Gut. 2008;57:77–83.
5. Stöhr T, Colin PJ, Ossig J, et al. Pharmacokinetic properties of remimazolam in subjects with hepatic or renal impairment. Br J Anaesth. 2021;127:415–23.